| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +9.69% | +0.46% | +9.23% | +4.48% | — |
| 14d | 4 | +50.00% | +11.96% | -0.58% | +12.54% | +1.03% | — |
| 30d | 4 | +75.00% | -1.98% | -3.73% | +1.76% | -8.06% | — |
| 60d | 4 | +25.00% | +12.86% | -0.07% | +12.93% | +0.00% | — |
| 90d | 4 | +25.00% | +37.60% | +1.92% | +69.30% | +69.30% | — |
| 180d | 4(2 pending) | +50.00% | +196.85% | +7.13% | +189.72% | +189.72% | — |
| 1y | 4(3 pending) | +0.00% | +159.32% | +14.77% | +144.55% | +144.55% | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KYTX KYVERNA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 325,000 | — | — | 325,000 | May 18, 2026 | May 20, 2026 ↗ | View → |
| IRWD IRONWOOD PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 136,612 | — | — | 297,213 | Mar 10, 2026 | Mar 12, 2026 ↗ | View → |
| IRWD IRONWOOD PHARMACEUTICALS INC | SALE Chief Financial Officer | 11,457 | $3.66 | $41.9K | 160,601 | Feb 24, 2026 | Feb 25, 2026 ↗ | View → |
| IRWD IRONWOOD PHARMACEUTICALS INC | SALE Chief Financial Officer | 10,487 | $3.81 | $40.0K | 172,058 | Feb 23, 2026 | Feb 25, 2026 ↗ | View → |
| IRWD IRONWOOD PHARMACEUTICALS INC | SALE Chief Financial Officer | 1,265 | $0.84 | $1.1K | 182,545 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| IRWD IRONWOOD PHARMACEUTICALS INC | SALE Chief Financial Officer | 12,052 | $1.76 | $21.2K | 183,810 | Feb 10, 2025 | Feb 12, 2025 ↗ | View → |
| IRWD IRONWOOD PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 111,111 | — | — | 195,862 | Jan 27, 2025 | Jan 29, 2025 ↗ | View → |